Loading stock data…
Core Laboratories Inc (CLB)
$11.67-0.13 (-1.10%)
Market ClosedLast close Jul 24
Core Laboratories Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Core Laboratories Inc. in the Energy sector is trading at $11.67 with a market capitalization of $575M. Wall Street consensus targets $15.50 (3 analysts), implying a +32.8% move over the next 12 months. The stock is currently near its 52-week low of $9.72, remaining 24.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +32.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $121.80M↓ | $138.25M↑ | $134.52M↑ | $130.16M↑ | $123.58M |
| Gross Profit | $15.96M↓ | $25.07M↓ | $26.03M↑ | $22.79M↑ | $20.40M |
| Operating Income | $1.24M↓ | $16.07M↑ | $15.34M↑ | $12.32M↑ | $6.75M |
| Net Income | -$789,000↓ | $4.95M↓ | $14.24M↑ | $10.64M↑ | -$154,000 |
Peer Comparison
XOMCVXCOP
Fundamentals
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segment...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$574.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.26%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.80%
Volume
Today's trading volume
640,561
Recent News
What's in Store for Core Laboratories Stock in Q2 Earnings?
CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Core Laboratory Stock?
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.
Core Laboratories, Excelerate Energy, and Black Stone Minerals Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after crude oil prices pulled back from the previous day's rally. West Texas Intermediate (WTI) crude fell 2.2% to settle near $71.88 per barrel, while the international benchmark Brent crude slipped below $77 per barrel.